Glucosamine Market Report Scope & Overview:

The Glucosamine Market Size was esteemed at USD 0.83 billion out of 2022 and is supposed to arrive at USD 1.15 billion by 2030, and develop at a CAGR of 4.2% over the forecast period 2023-2030.

Glucosamine is an amino sugar and perhaps of the most usually delivered mono-saccharide artificially by the hydrolysis of shellfish exoskeleton or maturation interaction of grains like wheat and corn. There are different restorative purposes of manufactured glucosamine. For example, oral glucosamine is utilized as a dietary enhancement for different ailments like joint torment and joint inflammation. Most regularly showcased planning of glucosamine incorporate glucosamine sulfate, glucosamine chondroitin, glucosamine hydrochloride, and N-acetylglucosamine. Glucosamine is normally utilized with chondroitin for the treatment of suggestive osteoarthritis of the knee in people.

Glucosamine Market Revenue Analysis

Get more information on Glucosamine Market - Request Sample Report

Thus, these enhancements are significantly taken by individuals with bone and joint torment as well as individuals experiencing temporomandibular joint (TMJ) jumble. Moreover, glucosamine supplements are likewise utilized in surface-level items as it supports the development of connective tissue and advance shedding (expulsion of dead skin) and hydration.

The development of the geriatric populace and issues connected with bone and joints, for example, osteoarthritis and joint inflammation significantly drive the development of this market. Likewise, the expansion deprived of glucosamine supplements for advancing sound development of skin and hair additionally energizes the market development. Further, less mindfulness among individuals in regards to the advantages of glucosamine supplements as well as the presence of many substitutes like omega 3 unsaturated fats, collagens, and fish oils combined with homegrown fixings is supposed to confine the development of the glucosamine supplements market.

Market Dynamics:

Driving Factors:

  • Expanding utilization of glucosamine in pet food.

  • The development in the geriatric populace and issues connected with bone.

Restraining Factors:

  • Less mindfulness among individuals concerning the advantages of glucosamine supplements.

Opportunities:

  • The expansion in the requirement for glucosamine supplements for advancing the sound development of skin and hair.

  • Joints like osteoarthritis and joint pain.

Challenges:

  • Presence of many substitutes like omega 3 unsaturated fats, collagens, and fish oils combined with natural fixings.

Market Estimations:

By Product Type:

Among Product types, the powder fragment is assessed to hold a significant piece of the pie in the worldwide glucosamine market during the gauge time frame attributable to the send-off of glucosamine items demonstrated for the treatment of sicknesses like rheumatoid joint pain.

By Application:

Among applications, the rheumatoid joint pain section is assessed to hold a significant piece of the pie in the worldwide glucosamine market during the estimated time frame, attributable to expanding pervasiveness of rheumatoid joint pain universally.

Key Market Segmentation:

By Product Type:

  • Powder

  • Tablets

  • Capsules

  • Liquid

By Application:

  • Rheumatoid Arthritis

  • Asthma

  • Inflammatory Bowel Disease

  • Others

Glucosamine Market Segmentation Analysis

Get Customized Report as per your Business Requirement - Request For Customized Report

Regional Analysis:

  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

North America rules the glucosamine market because of the presence of significant vital participants, nonstop mechanical turn of events, advanced medical care area, expanding commonness of illness, and expanding mindfulness towards wellbeing around here. The worldwide glucosamine market in the Asia-Pacific and Europe is supposed to develop during the figure time frame because of the rising innovative work exercises, developing business sectors, rising interest in the medical care area, and developing government support.

Key Players:

Bio-gen Extracts Private Limited, Panvo Organics Pvt Ltd, Pharma Base S.A., CAPTEK Softgel International Inc., TSI GROUP LTD, Cargill, Incorporated, CELLMARK AB., Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd.  (PXPC), Andra Medi Pharma Pvt. Ltd, Jiaxing Hengjie Biopharmaceutical Co., Ltd.

Panvo Organics Pvt Ltd-Company Financial Analysis

Company Landscape Analysis
Glucosamine Market Report Scope:
Report Attributes Details
Market Size in 2022 US$ 0.83 Billion
Market Size by 2030 US$ 1.15 Billion
CAGR CAGR of 4.2% From 2023 to 2030
Base Year 2022
Forecast Period 2023-2030
Historical Data 2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product Type (Powder, Tablets, Capsules, Liquid)
• By Application (Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Bio-gen Extracts Private Limited, Panvo Organics Pvt Ltd, Pharma Base S.A., CAPTEK Softgel International Inc., TSI GROUP LTD, Cargill, Incorporated, CELLMARK AB., Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd.  (PXPC), Andra Medi Pharma Pvt. Ltd, Jiaxing Hengjie Biopharmaceutical Co., Ltd.
Driving Factors • Expanding utilization of glucosamine in pet food.
• The development in the geriatric populace and issues connected with bone.
Restraints • Less mindfulness among individuals concerning the advantages of glucosamine supplements.